Smart MCs

🚀 Exciting News for Researchers Across the UK and Europe! We’re pleased to announce that TCS Biosciences Ltd is now an official distributor of Smart MCs products, helping researchers across the UK and Europe access our smart microcarriers, hydrogels, and microfluidics tools more easily. 🌍 Our product range is designed to support and enhance your research: ✅ Smart Microcarriers – Optimised surface area for better cell attachment and growth, broad compatibility with various cell types, and scalable solutions for all applications. ✅ Hydrogels – Developed for precise 3D cell culture and advanced tissue engineering applications. ✅ Microfluidics – High-performance tools for droplet generation, precise fluid control, and complex microfluidic systems. With this partnership, you can now get Smart MCs products directly from TCS Biosciences. For more information or to place an order, feel free to contact us or reach out to TCS Biosciences at sales@tcsgroup.co.uk. 🔗 Read more about our partnership here: https://lnkd.in/gTwfQvzm Let’s work together to advance scientific research. 🔬 #CellCulture #Biotech #Hydrogels #Microfluidics #SmartMCs #LifeSciences #ResearchTools #TCSBiosciences #Collaboration

We are thrilled to host Prof. Steve Oh, a renowned expert in cell therapy, for an insightful presentation titled: 🎤 “Mesenchymal Stem Cell Therapies: Promises Fulfilled and Potential New Applications” 🗓 New Date: Tuesday, 28 January 2025 🕒 New Time: 12:00 AM (Sydney Time, AEDT) 🌐 Accommodating Global Time Zones: • Singapore: 9:00 PM (SGT), 27 January 2025 • London: 1:00 PM (GMT), 27 January 2025 • Los Angeles: 5:00 AM (PST), 27 January 2025 • Dubai: 5:00 PM (GST), 27 January 2025 📍 Location: Online (via Zoom) Due to overwhelming global demand, we have adjusted the time to accommodate participants from different time zones. Register below to get the Zoom link and join us live, where you can listen to the presentation and ask your questions! The session will also be recorded and uploaded to YouTube. 🌟 What to Expect: Steve will dive deep into the evolving field of Mesenchymal Stromal Cells (MSCs), now widely known as Medicinal Signaling Cells, which have shown remarkable potential in tissue repair. Key highlights include: ✅ Clinical success stories in 13 diseases over the last 15 years, including the groundbreaking FDA approval of Mesoblast’s therapy for pediatric Graft vs. Host Disease. ✅ Emerging technologies: • Machine learning for osteoarthritis treatment. • Biodegradable microcarriers for scalable cell production. • Non-DMSO solutions for enhanced cell preservation. ✅ Future directions for allogeneic and engineered MSCs, focusing on cost reduction and increased accessibility. ✅ A brief overview of the International Society for Cell & Gene Therapy (ISCT), a global leader in cell and gene therapy innovation for over 31 years. 💡 This is a must-attend event for biotech professionals, researchers, and anyone interested in the future of regenerative medicine and cell manufacturing. 👉 Register Now: https://lnkd.in/gpED9WHu We look forward to seeing you there! Payar Lin Majid David Kenny Graham Khoon Tom Kris Christopher Zlatibor Vanouhi Murray Rouzbeh Mohsen David Fiona Gareth Millie UTS Startups Big Idea Ventures TCS Biosciences Ltd Mesoblast Limited RoosterBio Inc. CSIRO Thermo Fisher Scientific Cynata Therapeutics OmniaBio CCRM CCRM Nordic CCRM Australia Genetic Engineering & Biotechnology News University of Sydney UNSW University of Technology Sydney Macquarie University Royal Perth Hospital A*STAR - Agency for Science, Technology and Research #Biotech #Webinar #StemCellTherapy #CellTherapy #MSC #Innovation #RegenerativeMedicine #Biotechnology #Microcarriers

🔬Microcarriers in Adherent Cell Culture with a Funnel-Type Fluidized Bed Reactor A recent study introduces a funnel-type fluidized bed reactor that improves microcarrier-based cell culture efficiency for large-scale applications. Key Highlights 🔹 Stable Suspension: Funnel design prevents microcarrier settling and ensures uniform fluidization. 🔹 Low-Shear Environment: Gentle liquid flow protects sensitive cells like hMSCs. 🔹 Results: • L929 Cells: Achieved 1.45x higher cell density compared to 2D systems. • hMSCs: Delivered 1.2x higher density with consistent nutrient stability. This research addresses critical challenges in stem cell expansion, vaccine production, and cell therapy manufacturing. 🌟 At Smart MCs, we provide high-quality microcarriers to support bioreactor systems like the funnel-type fluidized bed reactor. 🔗 Read more in our blog: https://lnkd.in/gvxGTbci 📧 Have questions? Reach out to us at: info@smartmcs.com.au #Microcarriers #CellCulture #Bioreactors #StemCellExpansion #BiotechResearch #VaccineProduction #TherapeuticManufacturing #SmartMCs #Biotechnology

🎉 Happy New Year 2025 from Smart MCs! 🎉 As we turn the page to a new year, we reflect on an incredible journey through 2024. This past year was filled with milestones, progress, and partnerships shaping our path forward. We want to extend a heartfelt thank you to: 💡 Our dedicated team 🤝 Our valued partners and clients 🌟 The inspiring scientific community Your trust and collaboration have been the cornerstone of our success. In 2025, we are more committed than ever to delivering impactful solutions, advancing innovation, and empowering progress in biotechnology. Together, let’s shape a future driven by science, technology, and creativity. Here’s to a year of growth, collaboration, and shared achievements. Wishing everyone a prosperous, innovative, and successful 2025! Let’s continue to revolutionize the biotech landscape together. Cheers to new opportunities and achievements! 🧬💡 👉 Read more here: https://lnkd.in/gR6MjF47 #HappyNewYear2025 #Innovation #Biotechnology #ThankYou #NewYearGoals

🚨 What Mesoblast's MSC Approval Means for Cell Therapy Stakeholders 🚨 The FDA’s approval of the first-ever allogeneic MSC therapy is a monumental step forward for cell-based therapies! 🎉 It’s a clear sign that the industry is poised for incredible growth—but it also highlights the urgent need for scalable, cost-effective production solutions to meet increasing demand. 💡 What This Means for Stakeholders: ✅ A game-changing moment for MSC, iPSC, and exosome therapies. ✅ An urgent push for scalable and efficient biomanufacturing processes. If you are looking to scale your stem cell manufacturing, Smart MCs is here to support the industry with our cutting-edge microcarrier platforms: ✔️ From as little 100 mL to thousands of Litres and beyond ✔️ Achieve higher cell yields with lower costs and less labor. ✔️ Dissolvable microcarriers that do not require further filtration Take a look at the fantastic results our collaborators have generated at BTI, A*STAR in Singapore using our Microcarriers. Shout out to Dr. Alan Lam for the amazing work that is soon going to be published in a reputable journal! 🚀 The future of cell therapy is now. Check out our website to learn more! https://lnkd.in/gYfpMWYy #FDAApproval #CellTherapy #MSCs #StemCellProduction #ScalingUp #BiotechInnovation #SmartMCs #RegenerativeMedicine #StemCells #Microcarriers

🎄✨ Merry Christmas from the Smart MCs team! Wishing you a joyful season surrounded by love and laughter. May your Christmas be peaceful, happy, and heartwarming. Merry Christmas! 🎅 #MerryChristmas #SeasonGreetings #SmartMCs

🌟 Breaking News in Regenerative Medicine! 🌟 The FDA has approved Ryoncil (remestemcel-L-rknd), the first mesenchymal stromal cell (MSC) therapy to treat steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients! 🎉 This is a major milestone for cell therapy, providing new hope for children with limited treatment options. ✅ Why This Matters: SR-aGVHD, a life-threatening complication of stem cell transplantation, occurs when donor immune cells attack recipient tissues, causing damage to organs such as the skin, liver, and gut. Ryoncil, derived from healthy adult donor bone marrow, offers an approach to modulate immune responses and treat this challenging condition. 💡 Key Highlights: • Approved for patients as young as 2 months old. • Backed by clinical trials showing clinically meaningful outcomes. • Paves the way for innovation in MSC, iPSC, and exosome-based therapies. 🚀 Impact on Biotech: This approval is a win for the cell therapy industry, demonstrating the potential of MSCs in treating immune-related diseases. It’s also a call to action for scaling production to meet growing demand. 🌐 The future of regenerative medicine is here, and it’s transforming lives! 👉 Learn more about this development and its implications on our website: https://lnkd.in/gYfpMWYy #RegenerativeMedicine #CellTherapy #FDAApproval #StemCells #MSCTherapy #BiotechInnovation #SRaGVHD #BiotechNews #HealthInnovation #FutureOfMedicine #ScienceBreakthrough #HealthcareTransformation

🌟 New Publication - Serum-Free Cell Culture: A Sustainable and Scalable Solution for Cultured Meat 🌱 Cultured meat offers a sustainable and ethical alternative to traditional farming, reducing emissions, resource use, and animal slaughter. However, scaling production has been hindered by the high cost and animal-derived nature of fetal bovine serum (FBS). Recent research highlights microbial lysates, like those from Vibrio natriegens, as a cost-effective, sustainable alternative to FBS, paving the way for affordable, serum-free media. Key Benefits: 🔬 Enhanced Growth: Microbial lysates support long-term cell proliferation and differentiation. 💰 Cost Savings: VN40 medium, supplemented with microbial lysates, costs 99.2% less than FBS. 🌍 Sustainability: A greener, animal-free approach to cell culture. Read More 🌐: https://lnkd.in/gsbeci4w #CellCulture #SerumFreeMedia #MicrobialLysates #Sustainability #CultivatedMeat #RegenerativeMedicine #BiotechInnovation

5 Tips for Optimising Microcarrier Culture Agitation Agitation is a key factor in microcarrier-based cell cultures, ensuring proper mixing, oxygenation, and nutrient delivery. Striking the right balance is important to avoid issues like clumping or cell damage. Here are five tips to get it right: 1️⃣ Adjust shear stress to match your cell type. 2️⃣ Use intermittent agitation during seeding, then switch to continuous. 3️⃣ Balance speed—too slow causes clumping, and too fast leads to cell detachment. 4️⃣ Gradually increase speed as the culture develops. 5️⃣ Use controlled agitation to improve detachment and cleanup. At Smart MCs, we provide microcarriers tailored to meet the needs of different applications. 📧 Contact us at info@smartmcs.com.au. 📖 Read more here: https://lnkd.in/dKNetdJV. #CellCulture #Bioprocessing #Microcarriers #Biotech

🥩 Cultured Meat Innovation Spotlight: Forged Gras by Vow 🌱 Vow just launched Forged Gras, a cultured twist on foie gras. Another innovation in the cultured meat space to advance the sector! As the cultured meat industry evolves, advanced tools like microcarriers are key to achieving the texture and quality consumers expect. At Smart MCs, we’re proud to support this transformation with our microcarriers, empowering producers to push boundaries in cultured meat production. Visit our website to learn more! 💻 https://lnkd.in/gpPP78SN 📧 Have questions or ready to get started? Contact us at info@smartmcs.com.au to explore how we can support your cultured meat production. Together, let’s redefine the future of food! 🌍 #CulturedMeat #FoodInnovation #Sustainability #Biotech #FutureOfFood #AlternativeProteins #Microcarriers #FoodTech #FoodSustainability